Transient trimethylaminuria related to menstruation
<p>Abstract</p> <p>Background</p> <p>Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses ca...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
BMC,
2007-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_d90b49fad0dd4a0c9b85fd1b5bfcd4ad | ||
042 | |a dc | ||
100 | 1 | 0 | |a Yamazaki Hiroshi |e author |
700 | 1 | 0 | |a Cashman John R |e author |
700 | 1 | 0 | |a Shimizu Makiko |e author |
245 | 0 | 0 | |a Transient trimethylaminuria related to menstruation |
260 | |b BMC, |c 2007-01-01T00:00:00Z. | ||
500 | |a 10.1186/1471-2350-8-2 | ||
500 | |a 1471-2350 | ||
520 | |a <p>Abstract</p> <p>Background</p> <p>Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylaminuria in self-reported subjects suffering from malodor and even in healthy women harboring functionally active flavin-containing monooxygenase 3 (FMO3).</p> <p>Methods</p> <p>FMO3 metabolic capacity (conversion of trimethylamine to trimethylamine <it>N</it>-oxide) was defined as the urinary ratio of trimethylamine <it>N</it>-oxide to total trimethylamine.</p> <p>Results</p> <p>Self-reported Case (A) that was homozygous for inactive Arg500stop FMO3, showed decreased metabolic capacity of FMO3 (i.e., ~10% the unaffected metabolic capacity) during 120 days of observation. For Case (B) that was homozygous for common [Glu158Lys; Glu308Gly] <it>FMO3 </it>polymorphisms, metabolic capacity of FMO3 was almost ~90%, except for a few days surrounding menstruation showing < 40% metabolic capacity. In comparison, three healthy control subjects that harbored heterozygous polymorphisms for [Glu158Lys; Glu308Gly] <it>FMO3 </it>or homozygous for wild <it>FMO3 </it>showed normal (> 90%) metabolic capacity, however, on days around menstruation the FMO3 metabolic capacity was decreased to ~60-70%.</p> <p>Conclusion</p> <p>Together, these results indicate that abnormal FMO3 capacity is caused by menstruation particularly in the presence, in homozygous form, of mild genetic variants such as [Glu158Lys; Glu308Gly] that cause a reduced FMO3 function.</p> | ||
546 | |a EN | ||
690 | |a Internal medicine | ||
690 | |a RC31-1245 | ||
690 | |a Genetics | ||
690 | |a QH426-470 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n BMC Medical Genetics, Vol 8, Iss 1, p 2 (2007) | |
787 | 0 | |n http://www.biomedcentral.com/1471-2350/8/2 | |
787 | 0 | |n https://doaj.org/toc/1471-2350 | |
856 | 4 | 1 | |u https://doaj.org/article/d90b49fad0dd4a0c9b85fd1b5bfcd4ad |z Connect to this object online. |